Skip to main content

Advertisement

SpringerLink
Log in

Topically applied manganese-porphyrins BMX-001 and BMX-010 display a significant anti-inflammatory response in a mouse model of allergic dermatitis

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

In this study, we topically administered two antioxidant compounds, the manganese-porphyrin-derivatives BMX-001 and BMX-010, in a mouse model of allergic dermatitis and compared the efficacy for reduction of itch and inflammation. In vitro effects of BMX-001 and BMX-010 on keratinocytes, bone marrow derived dendritic cells (BMDCs) and T-cells were initially analysed. For assessment of scratching behaviour, BMX-001 and BMX-010 (0.01 and 0.1 %) were topically applied 16 h and/or 1 h before compound 48/80 or toluene-2,4,-diisocyanate (TDI) challenge in a TDI induced mouse dermatitis model. Additionally, assessment of allergic skin inflammation was performed in a similar manner in the TDI model. Post-treatment ear thickness was measured 24 h after TDI challenge and compared to basal values. The mice were sacrificed and the ear auricle was removed for further analysis. In vitro, both BMX substances significantly inhibited cytokine production of keratinocytes as well as of BMDC and T-cell proliferation. Topical treatment with BMX cream resulted in a significant decrease in scratching behaviour in the compound 48/80 model, but not in the TDI model. Mice treated with BMX-001 and BMX-010 showed a moderate dose dependent decrease in ear thickness, and interestingly, the concentration of the cytokines IL-1β and IL-4 in inflamed skin was reduced by 80–90 % by all treatment options. These first results suggest the potential benefit of a BMX-001 and BMX-010 cream for the treatment of allergic-inflammatory skin diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Aikawa T, Ito S, Shinohara M, Kaneko M, Kondo T, Yuasa M (2015) A drug formulation using an alginate hydrogel matrix for efficient oral delivery of the manganese porphyrin-based superoxide dismutase mimic. Biomater Sci 3(6):861–869

    Article  CAS  PubMed  Google Scholar 

  2. Akiyama T, Carstens E (2013) Neural processing of itch. Neuroscience 250:697–714

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Archambeau JO, Tovmasyan A, Pearlstein RD, Crapo JD, Batinic-Haberle I (2013) Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum. Redox Biol 1:599–607

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Batinic-Haberle I, Rajic Z, Tovmasyan A, Reboucas JS, Ye X, Leong KW, Dewhirst MW, Vujaskovic Z, Benov L, Spasojevic I (2011) Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics. Free Radic Biol Med 51(5):1035–1053

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Batinic-Haberle I, Reboucas JS, Spasojevic I (2010) Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential. Antioxid Redox Signal 13(6):877–918

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Batinic-Haberle I, Tovmasyan A, Roberts ER, Vujaskovic Z, Leong KW, Spasojevic I (2014) SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways. Antioxid Redox Signal 20(15):2372–2415

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Baumer W, Kietzmann M (2007) Effects of cyclosporin A and cilomilast on activated canine, murine and human keratinocytes. Vet Dermatol 18(2):107–114

    Article  PubMed  Google Scholar 

  8. Baumer W, Seegers U, Braun M, Tschernig T, Kietzmann M (2004) TARC and RANTES, but not CTACK, are induced in two models of allergic contact dermatitis. Effects of cilomilast and diflorasone diacetate on T-cell-attracting chemokines. Br J Dermatol 151(4):823–830

    Article  CAS  PubMed  Google Scholar 

  9. Baumer W, Tschernig T, Sulzle B, Seegers U, Luhrmann A, Kietzmann M (2003) Effects of cilomilast on dendritic cell function in contact sensitivity and dendritic cell migration through skin. Eur J Pharmacol 481(2–3):271–279

    Article  CAS  PubMed  Google Scholar 

  10. Baumer W, Wlaz P, Jennings G, Rundfeldt C (2010) The putative lipid raft modulator miltefosine displays immunomodulatory action in T-cell dependent dermal inflammation models. Eur J Pharmacol 628(1–3):226–232

    Article  CAS  PubMed  Google Scholar 

  11. Fukuyama T, Ehling S, Cook E, Baumer W (2015) Topically administered Janus-Kinase inhibitors tofacitinib and oclacitinib display impressive antipruritic and anti-inflammatory responses in a model of allergic dermatitis. J Pharmacol Exp Ther 354(3):394–405

    Article  CAS  PubMed  Google Scholar 

  12. Liu T, Ji RR (2013) New insights into the mechanisms of itch: are pain and itch controlled by distinct mechanisms? Pflugers Arch 465(12):1671–1685

    Article  CAS  PubMed  Google Scholar 

  13. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223(1):77–92

    Article  CAS  PubMed  Google Scholar 

  14. Orrenius S, Gogvadze V, Zhivotovsky B (2007) Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 47:143–183

    Article  CAS  PubMed  Google Scholar 

  15. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, Gieler U, Lipozencic J, Luger T, Oranje AP, Schafer T, Schwennesen T, Seidenari S, Simon D, Stander S, Stingl G, Szalai S, Szepietowski JC, Taieb A, Werfel T, Wollenberg A, Darsow U (2012) Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol 26(9):1176–1193

    Article  CAS  PubMed  Google Scholar 

  16. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, Gieler U, Lipozencic J, Luger T, Oranje AP, Schafer T, Schwennesen T, Seidenari S, Simon D, Stander S, Stingl G, Szalai S, Szepietowski JC, Taieb A, Werfel T, Wollenberg A, Darsow U (2012) Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol 26(8):1045–1060

    Article  CAS  PubMed  Google Scholar 

  17. Shim M, Powers KL, Ewing SJ, Zhu S, Smart RC (2005) Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation. Cancer Res 65(3):861–867

    CAS  PubMed  Google Scholar 

  18. Steinhoff M, Brzoska T, Luger TA (2001) Keratinocytes in epidermal immune responses. Curr Opin Allergy Clin Immunol 1(5):469–476

    CAS  PubMed  Google Scholar 

  19. Steinman RM (2007) Lasker Basic Medical Research Award. Dendritic cells: versatile controllers of the immune system. Nat Med 13(10):1155–1159

    Article  CAS  PubMed  Google Scholar 

  20. van de Wetering CI, Coleman MC, Spitz DR, Smith BJ, Knudson CM (2008) Manganese superoxide dismutase gene dosage affects chromosomal instability and tumor onset in a mouse model of T cell lymphoma. Free Radic Biol Med 44(8):1677–1686

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Wang YH, Xu XJ, Li HL (2014) Hepatoprotective effects of mimic of manganese superoxide dismutase against carbon tetrachloride-induced hepatic injury. Int Immunopharmacol 22(1):126–132

    Article  CAS  PubMed  Google Scholar 

  22. Werfel T (2009) The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. J Invest Dermatol 129(8):1878–1891

    Article  CAS  PubMed  Google Scholar 

  23. Wilson SR, The L, Batia LM, Beattie K, Katibah GE, McClain SP, Pellegrino M, Estandian DM, Bautista DM (2013) The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell 155(2):285–295

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This work was funded by BioMimetix JV, LLC. We deeply appreciate Dr. Sarah Ehling and Dr. Joy Rachel Ganchingco (North Carolina State College of Veterinary Medicine) for their variable suggestions and discussions.

Author information

Authors and Affiliations

  1. Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, 1060 William Moore Drive, Raleigh, NC, 27607, USA

    Kelsey Stover, Tomoki Fukuyama & Wolfgang Bäumer

  2. Joint Department of Biomedical Engineering, North Carolina State University and University of North Carolina, Chapel Hill, Chapel Hill, USA

    Ashlyn T. Young & Michael A. Daniele

  3. BioMimetix JV, LLC, Englewood, CO, USA

    Rebecca Oberley & James D. Crapo

  4. University of Nebraska Medical Center, Omaha, NE, USA

    Rebecca Oberley

  5. National Jewish Health, Denver, CO, USA

    James D. Crapo

Authors
  1. Kelsey Stover
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tomoki Fukuyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ashlyn T. Young
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael A. Daniele
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rebecca Oberley
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. James D. Crapo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wolfgang Bäumer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wolfgang Bäumer.

Ethics declarations

Conflict of interest

Authors K.S., T.F., M.A.D., K,T,Y., and W.B. have no conflicts of interest. J.D.C. is manager of BioMimetix JV, LLC, and holds equity. R.E.O.D. has equity in BioMimetix JV, LLC.

Additional information

K. Stover and T. Fukuyama shared first authorship.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stover, K., Fukuyama, T., Young, A.T. et al. Topically applied manganese-porphyrins BMX-001 and BMX-010 display a significant anti-inflammatory response in a mouse model of allergic dermatitis. Arch Dermatol Res 308, 711–721 (2016). https://doi.org/10.1007/s00403-016-1693-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-016-1693-0

Keywords

Search

Navigation